Results 11 to 20 of about 276,260 (291)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma

Patient Preference and Adherence, 2020
Christian Vogelberg,1 Bernd Brüggenjürgen,2 Hartmut Richter,3 Marek Jutel4,5 1Department of Pediatric Pneumology and Allergology, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany; 2Institute for ...
Vogelberg C, Brüggenjürgen B, Richter H, Jutel M   +3 more
doaj   +2 more sources

Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children [PDF]

Journal of Allergy and Clinical Immunology, 2023
Edwin Kim, Corinne Keet, Yamini V. Virkud, Stacy Chin, Ping Ye, Anusha Penumarti, Johanna M. Smeekens, Rishu Guo, Xiaohong Yue, Quefeng Li, Michael R. Kosorok, Michael D. Kulis, A Wesley Burks   +12 more
openalex   +2 more sources

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis. [PDF]

World Allergy Organ J, 2023
Zeng Y, Xiao H, Gao S, Li J, Yang C, Zeng Q, Luo X, Luo R, Chen X, Liu W.   +9 more
europepmc   +3 more sources

Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web platform AllergyVax®. [PDF]

World Allergy Organ J
Aarestrup MF, Nagato AC, Aarestrup PF, Cheloni EP, Aarestrup BJV, Amaral Correa JO, Aarestrup FM.   +6 more
europepmc   +3 more sources

Patient needs and benefits of sublingual immunotherapy for grass pollen-induced allergic rhinitis: an observational study.

Immunotherapy, 2021
Aim: Clinical efficacy of sublingual immunotherapy for grass pollen-induced allergic rhinitis (AR) needs to translate into patient benefit. Patients & methods: Patients received Oralair (Stallergenes, Antony, France) in real-life medical practice ...
T. Klein, M. Hadler, M. Augustin, C. Blome   +3 more
semanticscholar   +1 more source

Sublingual immunotherapy persistence and adherence in real‐world settings: A systematic review

International Forum of Allergy and Rhinology, 2022
Sublingual immunotherapy (SLIT) adherence in the literature is often evaluated in closely monitored trials that may impact patient behavior; real‐world SLIT adherence is relatively unknown.
Michelle Park, Shrey Kapoor, Julie S. Yi, Nanki Hura, Sandra Y. Lin   +4 more
semanticscholar   +1 more source

Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis

Frontiers in Immunology, 2023
Aim To systematically compare the efficacy and safety of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) in children with allergic rhinitis (AR).
Jiumei Yang, Sihong Lei
semanticscholar   +1 more source

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis

Pathogens, 2022
Sublingual immunotherapy for Japanese cedar pollinosis can improve the symptoms of allergic rhinitis and modify its natural course. However, sublingual immunotherapy requires a long treatment period and some patients do not respond to treatment.
Riyo Yoneda, Tomohisa Iinuma, Daiju Sakurai, Junya Kurita, Tomoyuki Arai, Yuri Sonobe, Syuji Yonekura, Yoshitaka Okamoto, Toyoyuki Hanazawa   +8 more
doaj   +1 more source

Eosinophilic esophagitis: A potential complication of sublingual immunotherapy [PDF]

Opšta Medicina, 2021
Introduction. Eosinophilic esophagitis (EoE) represents chronic, a local immune-mediated disease with symptoms of esophageal dysfunction and histologically eosinophil-predominant inflammation and requires immediate endoscopy. Male gender is a strong risk
Knežević Snežana B., Dugalić Branimir D.   +1 more
doaj   +1 more source

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis

Clinical and Translational Allergy, 2022
Background This study investigated patients' preference for allergy immunotherapy (AIT) administered as either sublingual immunotherapy‐tablets versus monthly or weekly subcutaneous immunotherapy (SCIT) from a Spanish patient perspective.
M. Bøgelund, A. Ingelmo, J. M. Ruiz, Adolfo Galán Vivó, Henrik Brandi, M. Pedersen, A. S. L. Loftager, M. Aagren   +7 more
semanticscholar   +1 more source